# Saul Centers, Inc.: overview

BFS · NYSE · CIK 907254 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bfs.md) · [Financials](/companies/bfs/financials.md) · [Filings](/companies/bfs/filings.md) · [Insiders](/companies/bfs/insiders.md)

Latest reported revenue: [$76.8m](/filings/0000907254-26-000049.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0000907254-26-000049).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [67.3](/filings/0000907254-25-000108.md) | [67.9 d](/filings/0000907254-26-000006.md) | [71.9](/filings/0000907254-26-000032.md) | [70.8](/filings/0000907254-26-000049.md) | [72.0](/filings/0000907254-25-000108.md) | [75.1 d](/filings/0000907254-26-000006.md) | [78.3](/filings/0000907254-26-000032.md) | [76.8](/filings/0000907254-26-000049.md) |
| Gross margin | % | [73.6%](/filings/0000907254-24-000100.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [72.8%](/filings/0000907254-25-000108.md) | [82.9% d](/filings/0000907254-26-000006.md) | [66.5%](/filings/0000907254-26-000032.md) | [68.7%](/filings/0000907254-26-000049.md) | [69.1%](/filings/0000907254-25-000108.md) | [65.4% d](/filings/0000907254-26-000006.md) | [66.0%](/filings/0000907254-26-000032.md) | [67.7%](/filings/0000907254-26-000049.md) |
| Net margin | % | [21.5%](/filings/0000907254-25-000108.md) | [11.9% d](/filings/0000907254-26-000006.md) | [13.6%](/filings/0000907254-26-000032.md) | [15.1%](/filings/0000907254-26-000049.md) | [14.6%](/filings/0000907254-25-000108.md) | [8.7% d](/filings/0000907254-26-000006.md) | [11.7%](/filings/0000907254-26-000032.md) | [11.4%](/filings/0000907254-26-000049.md) |
| Diluted EPS | $ per share | [0.48](/filings/0000907254-25-000108.md) | not reported | [0.29](/filings/0000907254-26-000032.md) | [0.33](/filings/0000907254-26-000049.md) | [0.32](/filings/0000907254-25-000108.md) | not reported | [0.26](/filings/0000907254-26-000032.md) | [0.24](/filings/0000907254-26-000049.md) |
| Free cash flow | $m | [(28.3) d](/filings/0000907254-25-000108.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [239](/filings/0000907254-24-000020.md) | [246](/filings/0000907254-25-000022.md) | [257](/filings/0000907254-26-000006.md) | [269](/filings/0000907254-26-000006.md) | [290](/filings/0000907254-26-000006.md) |
| Gross margin | % | [74.2%](/filings/0000907254-24-000020.md) | [73.8%](/filings/0000907254-24-000020.md) | [73.9%](/filings/0000907254-24-000020.md) | not reported | not reported |
| Operating margin | % | not reported | [73.4%](/filings/0000907254-25-000022.md) | [73.6%](/filings/0000907254-26-000006.md) | [75.8%](/filings/0000907254-26-000006.md) | [67.4%](/filings/0000907254-26-000006.md) |
| Net margin | % | [20.2%](/filings/0000907254-24-000020.md) | [20.4%](/filings/0000907254-25-000022.md) | [20.5%](/filings/0000907254-26-000006.md) | [18.8%](/filings/0000907254-26-000006.md) | [12.9%](/filings/0000907254-26-000006.md) |
| Diluted EPS | $ per share | [1.57](/filings/0000907254-24-000020.md) | [1.63](/filings/0000907254-25-000022.md) | [1.73](/filings/0000907254-26-000006.md) | [1.63](/filings/0000907254-26-000006.md) | [1.09](/filings/0000907254-26-000006.md) |
| Free cash flow | $m | [62.5](/filings/0000907254-24-000020.md) | [4.3](/filings/0000907254-25-000022.md) | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bfs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $84.3m | 2,254,667 |  | Added +141,990 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $48.7m | 1,302,765 |  | Reduced −13,515 |
| [ADAGE CAPITAL PARTNERS GP, L.L.C.](/funds/1165408.md) | 2026-06-30 | $27.0m | 723,198 |  | Reduced −11,603 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $21.3m | 570,914 |  | Added +51,504 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $20.6m | 550,628 |  | Reduced −32,655 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $15.6m | 416,391 |  | Reduced −182,803 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $13.5m | 361,256 |  | Added +25,608 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $12.8m | 342,206 |  | Added +79,488 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $8.8m | 235,690 |  | Added +24,432 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $7.6m | 202,295 |  | Added +50 |

## Recent filings

[All 1,710 filings](/companies/bfs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:19 ET | [10-Q](/filings/0000907254-26-000049.md) | Quarterly report, period 2026-06-30 | 0000907254-26-000049 |
| 2026-08-06 | 16:15 ET | [8-K](/filings/0000907254-26-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000907254-26-000047 |
| 2026-05-11 | 16:22 ET | [8-K](/filings/0000907254-26-000034.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000907254-26-000034 |
| 2026-05-07 | 16:25 ET | [10-Q](/filings/0000907254-26-000032.md) | Quarterly report, period 2026-03-31 | 0000907254-26-000032 |
| 2026-05-07 | 16:23 ET | [8-K](/filings/0000907254-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000907254-26-000031 |
| 2026-03-23 | 16:10 ET | [DEF 14A](/filings/0000907254-26-000025.md) | Proxy statement, period 2026-05-08 | 0000907254-26-000025 |
| 2026-02-27 | 16:31 ET | [10-K](/filings/0000907254-26-000006.md) | Annual report, period 2025-12-31 | 0000907254-26-000006 |
| 2026-02-27 | 16:14 ET | [8-K](/filings/0000907254-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000907254-26-000003 |
| 2025-11-26 | 13:20 ET | [8-K](/filings/0000907254-25-000113.md) | 5.02 Departure or appointment of officers or directors | 0000907254-25-000113 |
| 2025-11-06 | 16:29 ET | [10-Q](/filings/0000907254-25-000108.md) | Quarterly report, period 2025-09-30 | 0000907254-25-000108 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000907254-26-000006.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c43c99e1-532d-42b2-a2a0-1b432a4e1be5)

## About the filer

- CIK: 907254
- Tickers: BFS, BFS-PD, BFS-PE
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:57 ET. No prices; not investment advice.